JH
Jennifer Hellawell
Cardiovascular Disease
Credentials: · · · ·
History
- 2014–2016
- 2008–2011
Internal Medicine
- 2004–2008
Doctor of Medicine
Research
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Nature Medicine · 2022 · 202 citations
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
New England Journal of Medicine · 2024 · 198 citations
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
New England Journal of Medicine · 2024 · 197 citations
9 papers
8 papers
7 papers
- OM
4 papers
3 papers
- JN
3 papers
- KL
3 papers
2 papers
